UNSPSC 51172136: Meladrazine or meladrazine tartrate

This classification denotes an antispasmotic agent with the molecular formulas C11H23N7 and C11H23N7.C4H6O6, preparations that US FDA regulates as active ingredients or moieties under Unique Ingredient Identifiers 2V6Z0JG2X0 and 7F3DYQ3H7H, the base compound being chemically known as 1,3,5-triazin-2(1h)-one, 4,6-bis(diethylamino)-, hydrazone (9ci) but generally known as meladrazine, which bears US NIH Compound Identifier 71679. European Medicines Agency schedules Meladrazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB08717MIG and SUB03125MIG.

UNSPSC 51172136 Meladrazine or meladrazine tartrate is a Commodity code that appears in state and local procurement records with minimal direct relevance to the code's nominal pharmaceutical scope. The recent opportunities tagged under this code do not solicit meladrazine or meladrazine tartrate itself; instead, they cover offender drug testing services, pharmacy benefit program direct-contracting capabilities, and generic multi-source pharmaceutical distribution agreements. The Collin County Community Supervision and Corrections Department RFP for offender specimen collection and drug testing services (due July 23, 2026) represents the most concrete match, as it encompasses immunoassay screening, LC/MS/MS or GC/MS confirmation, and ancillary testing methodologies—functions that may use meladrazine as a reference standard or testing reagent—but the solicitation does not name meladrazine specifically and focuses on testing operations and staffing rather than pharmaceutical procurement. The Texas HHS Commission RFI on direct-to-manufacturer prescriptions and the MMCAP generic multi-source pharmaceuticals RFP (due March 26, 2026) address broader pharmaceutical supply and pricing arrangements unrelated to the code's specific active pharmaceutical ingredient.

Geographic activity centers on Texas and Minnesota based on the three recent opportunities, with issuing bodies spanning a county corrections department, a state health agency, and a multistate cooperative purchasing alliance. The Collin County RFP carries an estimated contract value of $600,000 with a two-year initial term plus optional one-year renewals through September 1, 2026, while MMCAP's pharmaceutical contract RFP covers multiple states with performance through June 30, 2028. The code shows no clear pattern of substantive recent procurement activity specifically for meladrazine or meladrazine tartrate products; the tagging appears incidental to broader testing, supply, or pharmacy program solicitations rather than direct demand for the pharmaceutical ingredient itself.